Phase 4 Psoriasis Trial, Recruiting NCT05858632 Sponsor: University of California, San Francisco Condition: Psoriasis
Back to Psoriasis

Phase 4 Psoriasis Trial, Recruiting

NCT05858632
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People with a scalp psoriasis severity score (called a PSSI score) of 12 or higher, indicating moderate to severe scalp psoriasis

Who may not be able to join:

  • People who have taken medications that suppress the immune system in the last 4 weeks
  • People who are currently pregnant
  • People who are breastfeeding
  • People with a serious condition that severely weakens the immune system, whether from a genetic condition or an infection such as HIV (confirm with trial site)
  • People who have tuberculosis or another serious active infection
  • People with an active cancer affecting the body's systems
  • Men who are currently trying to conceive a child
  • People with any other condition or abnormality that the trial investigator believes could affect their safety or the reliability of the trial results

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Raymond Cho, MD, PhD, University of California, San Francisco

Phone: 415 575 0524

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
1 July 2023
Est. completion
30 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in psoriasis scalp severity index score (PSSI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov